Key Metrics
CiteScore 

5.9
H-Index 

74
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

1.13
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Breast Cancer
Clinical Breast Cancer Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Breast Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Breast Cancer
Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control: A Retrospective Cohort Study.
- 1 Aug 2026
- Clinical breast cancer
Real-World Feasibility Assessment of Short-Course Preoperative Endocrine Therapy Using the Ki67 Biomarker in an Australian Cohort of Patients With Estrogen Receptor-Positive Early Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study.
- 1 Aug 2026
- Clinical breast cancer
The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Comparison of Clinicopathological Features and Survival Between Distant Lymph Node Metastasis and Distant Micrometastasis in Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Breast Cancer Location Predicts Sentinel Lymph Node Metastasis in Clinically Node Negative Patients With Invasive Breast Cancer Treated With Upfront Surgery.
- 1 Aug 2026
- Clinical breast cancer
Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control: A Retrospective Cohort Study.
- 1 Aug 2026
- Clinical breast cancer
Real-World Feasibility Assessment of Short-Course Preoperative Endocrine Therapy Using the Ki67 Biomarker in an Australian Cohort of Patients With Estrogen Receptor-Positive Early Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study.
- 1 Aug 2026
- Clinical breast cancer
The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Comparison of Clinicopathological Features and Survival Between Distant Lymph Node Metastasis and Distant Micrometastasis in Breast Cancer.
- 1 Aug 2026
- Clinical breast cancer
Breast Cancer Location Predicts Sentinel Lymph Node Metastasis in Clinically Node Negative Patients With Invasive Breast Cancer Treated With Upfront Surgery.
- 1 Aug 2026
- Clinical breast cancer